Jazz Pharmaceuticals JAZZ paid Tiber Creek Group $60K for lobbying in Q2 2023 · Health Issues, Medical and 1 more issue

Trade details

Type: Lobbying report
Amount: $60,000
Quarter: Q2 2023
Stock: Jazz Pharmaceuticals JAZZ
Client: Jazz Pharmaceuticals
Reported: 23/07/14

Up 0.0% from last quarter

What else happened in Jazz Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/05/31~23/07/30

Jazz Pharmaceuticals's other lobbying reports

Jazz Pharmaceuticals
LobbyingJazz Pharmaceuticals
Lobbying
Jazz Pharmaceuticals
JAZZ
$80K
$80K
Reported 07/20
for Q2
Jazz Pharmaceuticals
LobbyingJazz Pharmaceuticals
Lobbying
Jazz Pharmaceuticals
JAZZ
$490K
$490K
Reported 07/20
for Q2
Jazz Pharmaceuticals
LobbyingJazz Pharmaceuticals
Lobbying
Jazz Pharmaceuticals
JAZZ
$50K
$50K
Reported 07/20
for Q2
Jazz Pharmaceuticals
LobbyingJazz Pharmaceuticals
Lobbying
Jazz Pharmaceuticals
JAZZ
$50K
$50K
Reported 07/20
for Q2
Jazz Pharmaceuticals
LobbyingJazz Pharmaceuticals
Lobbying
Jazz Pharmaceuticals
JAZZ
$50K
$50K
Reported 07/19
for Q2